Vol 8: An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema.Report as inadecuate



 Vol 8: An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema.


Vol 8: An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 8: An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema.
This article is from Clinical Ophthalmology (Auckland, N.Z.), volume 8.AbstractBackground: The purpose of this study was to evaluate the safety and tolerability of pegaptanib in patients with diabetic macular edema. Methods: An open-label, multicenter, noncomparative, one-year study of approximately 500 patients was planned. Recruitment was termina

Author: Sivaprasad, Sobha; Browning, Richard C; Starita, Carla

Source: https://archive.org/







Related documents